Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by LaserStock29on May 04, 2020 1:05pm
182 Views
Post# 30984180

RE:RE:RE:RE:RE:RE:RE:RE:The Longest Day

RE:RE:RE:RE:RE:RE:RE:RE:The Longest Day
Hempdoc wrote: LS wrote:

Hempdoc.. are you suggesting that Lond on and Novascotia will be closed all through the summer?

Unless Theralase has onboarded MD Anderson to the exact same 'ready-level' as London and Novascotia.. it takes months to onboard and ready hospitals..

So i dont quite follow the 'quickly' in the US sentiment.


NS

The NSHA institution is affiliated with the Urology Department at Dalhousie (“UDD”) University of Medicine, an innovative leader in urological oncology research. UDD evaluates new technologies designed to improve the lives of people suffering from urological cancers. Each year, more than 300 people are diagnosed with bladder cancer and seek attention in Nova Scotia.2 UDD doctors have extensive experience providing quality of care for bladder cancer patients while maintaining an active research role to enhance overall patient care.

Dr. Ricardo Rendon, MD, FRCSC, Professor in the Department of Urology and Director of Clinical Trial of Dalhousie University in Halifax stated that “We are excited to work with Theralase for the NMIBC clinical trial. Tackling cancer is a crucial topic and a priority for this region, and I am pleased that NSHA is able to contribute to the growth of innovative cancer research by taking part in this leading Pivotal PhotoDynamic Therapy (“PDT”) study.”


Shawn Shirazi, Ph.D., CEO of Theralase, stated that “I am pleased to announce the addition of NSHA and Dr. Rendon as Principal Investigator. Dr. Rendon is considered an expert in the field with a clinical focus on all areas of uro-oncology


NovaScotia Coronavirus Data

Id say Novascotia is doing very well..  curve is flattening.. single digits..


No problem to get 4 done in NovaScotia once they can get going.
UHN can take 1 more
McGill 1 more
London can do 2

theres your 20...
 

I think London & NS will certainly be up & running for the summer.  If it weren't for various bureaucracies, they should be up & running yesterday.  If up & running in the next couple of weeks, they should hit 20 by fall (w/o US).The US "hybrid" system as Quattro accurately referred to it, is a well-oiled machine as it relates to major cancer centers.  MD Anderson certainly doesn't have to wait for stage 4 cancer or death's door to treat.  As for USA trial sites, our contracted TMO should have at least 4 sites ready to enroll/treat soon after we get IND approval...certainly won't be months imo.




Appreciate the response.

Yes the TMO agreement is an excellent point.  I hope that is a 'force multiplier' when the IND gets approved Theralase would emphasise this TMO and the status of what hospitals are ready to go in the USA, and investors see our 'progress'  prior to entering the USA via treatments..

Cheers... time to move that decimal place over from petri dish preclinical -valuations
Bullboard Posts